Latest Insider Transactions at Silverback Therapeutics, Inc. (SBTX)
This section provides a real-time view of insider transactions for Silverback Therapeutics, Inc. (SBTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Silverback Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Silverback Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 28
2023
|
Alexander A Fitzpatrick Chief Legal Officer |
BUY
Open market or private purchase
|
Direct |
40,000
+48.21%
|
$120,000
$3.62 P/Share
|
|
Sep 21
2023
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
2,700,000
+12.63%
|
$8,100,000
$3.4 P/Share
|
|
Sep 01
2023
|
Laura Shawver |
SELL
Open market or private sale
|
Direct |
100,000
-32.22%
|
$700,000
$7.71 P/Share
|
|
Sep 01
2023
|
Laura Shawver |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+12.6%
|
$100,000
$1.27 P/Share
|
|
Aug 29
2023
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
500,000
+5.87%
|
$3,000,000
$6.2 P/Share
|
|
Aug 29
2023
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
3,750,000
+39.04%
|
$22,500,000
$6.2 P/Share
|
|
Aug 29
2023
|
Peter A. Thompson Director |
BUY
Open market or private purchase
|
Indirect |
500,000
+5.87%
|
$3,000,000
$6.2 P/Share
|
|
Aug 04
2023
|
Laura Shawver |
SELL
Open market or private sale
|
Direct |
18,897
-8.24%
|
$132,279
$7.06 P/Share
|
|
Aug 04
2023
|
Laura Shawver |
BUY
Exercise of conversion of derivative security
|
Direct |
18,897
+7.62%
|
$18,897
$1.27 P/Share
|
|
Aug 03
2023
|
Laura Shawver |
SELL
Open market or private sale
|
Direct |
26,107
-11.04%
|
$182,749
$7.01 P/Share
|
|
Aug 03
2023
|
Laura Shawver |
BUY
Exercise of conversion of derivative security
|
Direct |
26,107
+9.94%
|
$26,107
$1.27 P/Share
|
|
Aug 02
2023
|
Laura Shawver |
SELL
Open market or private sale
|
Direct |
36,281
-14.71%
|
$253,967
$7.09 P/Share
|
|
Aug 02
2023
|
Laura Shawver |
BUY
Exercise of conversion of derivative security
|
Direct |
36,281
+12.82%
|
$36,281
$1.27 P/Share
|
|
Aug 01
2023
|
Laura Shawver |
SELL
Open market or private sale
|
Direct |
18,715
-8.17%
|
$131,005
$7.19 P/Share
|
|
Aug 01
2023
|
Laura Shawver |
BUY
Exercise of conversion of derivative security
|
Direct |
18,715
+7.55%
|
$18,715
$1.27 P/Share
|
|
Jul 07
2023
|
Laura Shawver |
SELL
Open market or private sale
|
Direct |
8,858
-4.04%
|
$53,148
$6.36 P/Share
|
|
Jul 07
2023
|
Laura Shawver |
BUY
Exercise of conversion of derivative security
|
Direct |
8,858
+3.88%
|
$8,858
$1.27 P/Share
|
|
Jul 06
2023
|
Laura Shawver |
SELL
Open market or private sale
|
Direct |
33,510
-13.74%
|
$201,060
$6.34 P/Share
|
|
Jul 06
2023
|
Laura Shawver |
BUY
Exercise of conversion of derivative security
|
Direct |
33,510
+12.08%
|
$33,510
$1.27 P/Share
|
|
Jul 05
2023
|
Laura Shawver |
SELL
Open market or private sale
|
Direct |
31,112
-12.89%
|
$186,672
$6.41 P/Share
|
|
Jul 05
2023
|
Laura Shawver |
BUY
Exercise of conversion of derivative security
|
Direct |
31,112
+11.41%
|
$31,112
$1.27 P/Share
|
|
Jul 03
2023
|
Laura Shawver |
SELL
Open market or private sale
|
Direct |
26,520
-11.2%
|
$159,120
$6.72 P/Share
|
|
Jul 03
2023
|
Laura Shawver |
BUY
Exercise of conversion of derivative security
|
Direct |
26,520
+10.07%
|
$26,520
$1.27 P/Share
|
|
Jun 02
2023
|
Laura Shawver |
SELL
Open market or private sale
|
Direct |
26,941
-11.35%
|
$161,646
$6.95 P/Share
|
|
Jun 02
2023
|
Laura Shawver |
BUY
Exercise of conversion of derivative security
|
Direct |
26,941
+10.2%
|
$26,941
$1.27 P/Share
|
|
Jun 01
2023
|
Laura Shawver |
SELL
Open market or private sale
|
Direct |
73,059
-25.78%
|
$438,354
$6.8 P/Share
|
|
Jun 01
2023
|
Laura Shawver |
BUY
Exercise of conversion of derivative security
|
Direct |
73,059
+20.5%
|
$73,059
$1.27 P/Share
|
|
May 17
2023
|
Richard E Lowenthal PRESIDENT AND CEO |
BUY
Bona fide gift
|
Indirect |
2,100,000
+41.67%
|
-
|
|
May 17
2023
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Bona fide gift
|
Indirect |
1,050,000
-24.27%
|
-
|
|
May 17
2023
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Bona fide gift
|
Direct |
1,050,000
-20.28%
|
-
|
|
May 17
2023
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
BUY
Bona fide gift
|
Indirect |
2,100,000
+41.67%
|
-
|
|
May 17
2023
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Bona fide gift
|
Indirect |
1,050,000
-20.28%
|
-
|
|
May 17
2023
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Bona fide gift
|
Direct |
1,050,000
-24.27%
|
-
|
|
May 09
2023
|
Laura Shawver |
SELL
Open market or private sale
|
Direct |
42,900
-16.94%
|
$214,500
$5.31 P/Share
|
|
May 09
2023
|
Laura Shawver |
BUY
Exercise of conversion of derivative security
|
Direct |
42,900
+14.49%
|
$42,900
$1.27 P/Share
|
|
May 08
2023
|
Laura Shawver |
SELL
Open market or private sale
|
Direct |
57,100
-21.35%
|
$342,600
$6.16 P/Share
|
|
May 08
2023
|
Laura Shawver |
BUY
Exercise of conversion of derivative security
|
Direct |
57,100
+17.59%
|
$57,100
$1.27 P/Share
|
|
Nov 29
2022
|
Kathleen D. Scott Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
8,250
+50.0%
|
$49,500
$6.24 P/Share
|
|
Nov 09
2022
|
Laura Shawver |
SELL
Open market or private sale
|
Direct |
43,896
-17.27%
|
$175,584
$4.58 P/Share
|
|
Nov 08
2022
|
Rajeev Dadoo |
BUY
Grant, award, or other acquisition
|
Indirect |
3,009,677
+50.0%
|
-
|
|
Nov 08
2022
|
Michael Kelly |
BUY
Grant, award, or other acquisition
|
Indirect |
83,225
+50.0%
|
-
|
|
Nov 08
2022
|
Richard E Lowenthal PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Indirect |
7,872,554
+50.0%
|
-
|
|
Nov 08
2022
|
Richard E Lowenthal PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
5,176,822
+50.0%
|
-
|
|
Nov 08
2022
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Indirect |
7,872,554
+50.0%
|
-
|
|
Nov 08
2022
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
4,326,854
+50.0%
|
-
|
|
Nov 08
2022
|
Ra Capital Management, L.P. |
BUY
Grant, award, or other acquisition
|
Indirect |
3,009,678
+50.0%
|
-
|
|
Nov 08
2022
|
Pratik Shah |
BUY
Grant, award, or other acquisition
|
Indirect |
10,156,204
+50.0%
|
-
|
|
Nov 08
2022
|
Justin Chakma Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
236,380
+50.0%
|
-
|
|
Aug 05
2022
|
Laura Shawver |
BUY
Exercise of conversion of derivative security
|
Direct |
78,740
+23.65%
|
$78,740
$1.27 P/Share
|
|
May 02
2022
|
Russ Hawkinson Sr. Vice President of Finance |
BUY
Grant, award, or other acquisition
|
Direct |
28,335
+43.2%
|
-
|